Patents by Inventor Junichi Yamagishi

Junichi Yamagishi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5401643
    Abstract: A simple and efficient method of preparing active recombinant human neutrophil chemotactic factor. The human neutrophil chemotactic factor (NCF) is solubilized from a transformant cell homogenate using urea or guanidine hydrochloride. The polypeptide is further purified from the solution using conventional protocols such as CM-Sepharose CL-6B, HW-55 column, etc.. By using this method, large amounts of active human NCF can be recovered and purified.
    Type: Grant
    Filed: March 23, 1992
    Date of Patent: March 28, 1995
    Assignees: Dainippon Pharmaceutical Co., Ltd., The United States of America as represented by the Department of Health and Human Services
    Inventors: Masaaki Yamada, Ryuji Furuta, Junichi Yamagishi, Kouji Matsushima
  • Patent number: 5376639
    Abstract: DNAs encoding polypeptides having interleukin 1, vectors inserted with said DNAs, hosts transformed with said recombinant vectors, polypeptides having interleukin 1 activity which are produced by cultivation of the transformed hosts, derivatives of the polypeptides, pharmaceutical composition containing said polypeptides or derivatives, their use as an antitumor or antiinfectious agent, and processes for the preparation thereof.
    Type: Grant
    Filed: September 30, 1992
    Date of Patent: December 27, 1994
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Masaaki Yamada, Yasuji Furutani, Michiko Yamayoshi, Mitsue Notake, Junichi Yamagishi
  • Patent number: 5341862
    Abstract: In a flame-retardant rubber tire comprising an outer rubber body portion consisting essentially of a tread rubber layer, a sidewall rubber layer extending inward from each side edge of the tread rubber layer toward the vicinity of a bead portion in radial direction and a rubber chafer layer arranged in the vicinity of the bead portion, a flame-retardant rubber composition having an oxygen index of not less than 19.8 but not more than 27.5 is disposed so as to amount at least 20% by weight of the tread rubber layer. Such rubber tires are used in electric vehicles, automobiles, airplanes and the like and have excellent self-extinguishing property and flame-delaying property without damaging other rubber properties.
    Type: Grant
    Filed: November 12, 1992
    Date of Patent: August 30, 1994
    Assignee: Bridgestone Corporation
    Inventors: Takatsugu Hashimoto, Keizo Akutagawa, Kazuo Yagawa, Makoto Tanaka, Junichi Yamagishi, Kazuo Hachiya
  • Patent number: 5340867
    Abstract: A flame-retardant rubber composition has an oxygen index of 19.8-27.5 and comprises not more than 24% by weight of red phosphorus as a flame retardant based on the rubber composition and a nitrile group-containing elastomer as a flame-retardant polymer component as a part of rubber ingredients constituting the rubber composition. Such flame-retardant rubber compositions are very useful in applications such as industrial goods, tire and the like strongly requiring the fire preventing function.
    Type: Grant
    Filed: November 4, 1992
    Date of Patent: August 23, 1994
    Assignee: Bridgestone Corporation
    Inventors: Kazuo Yagawa, Takatsugu Hashimoto, Junichi Yamagishi, Kazuo Hachiya, Satoshi Takezawa
  • Patent number: 5306627
    Abstract: An expression vector in which a DNA encoding a human neutrophil chemotactic factor polypeptide is inserted, a transformant (a host cell transformed with the expression vector), and a process for production of the said polypeptide by using the said transformant.
    Type: Grant
    Filed: June 4, 1991
    Date of Patent: April 26, 1994
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Masaaki Yamada, Ryuji Furuta, Junichi Yamagishi, Kouji Matsushima, Teizo Yoshimura
  • Patent number: 5290917
    Abstract: Novel polypeptides having a modified amino acid sequence of human interleukin 1.alpha. polypeptides in which a certain amino acid residue(s) in said amino acid sequence is(are) exchanged for other amino acid residue(s). Said polypeptides having no capacity of induction of production of prostaglandin E.sub.2 while maintaining other biological activities of human interleukin 1 such as activation of lymphocyte and being expected to be useful as a medicament.
    Type: Grant
    Filed: April 5, 1991
    Date of Patent: March 1, 1994
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Michiko Yamayoshi, Hitoshi Kawashima, Junichi Yamagishi, Hirotada Kotani, Ryuji Furuta, Toshikazu Fukui
  • Patent number: 4990455
    Abstract: A human TNF polypeptide mutant having an amino acid sequence of modified human TNF polypeptide, a DNA having a base sequence encoding the above human TNF polypeptide mutant and a method of producing the above human TNF polypeptide mutant by culturing a host transformed with a vector having inserted therein the above DNA. The above human TNF polypeptide mutant is soluble and has antitumor activity.
    Type: Grant
    Filed: June 22, 1987
    Date of Patent: February 5, 1991
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Junichi Yamagishi, Hitoshi Kawashima, Ryuji Furuta, Hirotada Kotani, Katuhisa Nakata